Cargando…

Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals

In spite of existing cases of severe viral infections with a high mortality rate, there are not enough antiviral drugs and vaccines available for the prevention and treatment of such diseases. In addition, the increasing reports of the emergence of viral epidemics highlight, the need for novel molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mousavi Maleki, Masoumeh Sadat, Sardari, Soroush, Ghandehari Alavijeh, Ali, Madanchi, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702942/ https://www.ncbi.nlm.nih.gov/pubmed/36466430 http://dx.doi.org/10.1007/s10989-022-10477-z

Ejemplares similares

Bromelain-loaded nanocomposites decrease inflammatory and cytotoxicity effects of gliadin on Caco-2 cells and peripheral blood mononuclear cells of celiac patients
por: Mousavi Maleki, Masoumeh Sadat, et al.
Publicado: (2023)

Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs
por: Ismail, Magda M. F., et al.
Publicado: (2022)

Recent patent applications in antiviral vaccines
Publicado: (2005)

Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
por: Tompa, Dharma Rao, et al.
Publicado: (2021)

THPdb: Database of FDA-approved peptide and protein therapeutics
por: Usmani, Salman Sadullah, et al.
Publicado: (2017)

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus
por: Jasenosky, Luke D., et al.
Publicado: (2019)

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
por: Park, Su-Jin, et al.
Publicado: (2020)

Identification of FDA Approved Antiviral Drugs for COVID-19 Treatment using Unbiased Virtual Screening
por: Greer, Rory, et al.
Publicado: (2021)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs
por: Sun, Ren, et al.
Publicado: (2013)

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library
por: Pascoalino, Bruno S., et al.
Publicado: (2016)

Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2021)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Antiviral peptides as promising therapeutic drugs
por: Vilas Boas, Liana Costa Pereira, et al.
Publicado: (2019)

Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
por: Pirzada, Rameez Hassan, et al.
Publicado: (2021)

Antiviral Host Defence Peptides
por: Sousa, Filipa Henderson, et al.
Publicado: (2016)

Antiviral Peptides: Identification and Validation
por: Agarwal, Garima, et al.
Publicado: (2020)

Lutathera(®): The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
por: Hennrich, Ute, et al.
Publicado: (2019)

Ebanga™: The most recent FDA-approved drug for treating Ebola
por: Taki, Elahe, et al.
Publicado: (2023)

Antiviral peptides against Coronaviridae family: A review
por: Heydari, Hamid, et al.
Publicado: (2021)

Cell-Penetrating Peptides for Antiviral Drug Development
por: Delcroix, Melaine, et al.
Publicado: (2010)

The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo
por: Alburquerque-González, Begoña, et al.
Publicado: (2021)

Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides
por: Ali, Farman, et al.
Publicado: (2023)

High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses
por: Ding, Cuiling, et al.
Publicado: (2022)

Antimicrobial Peptides as Potential Antiviral Factors in Insect Antiviral Immune Response
por: Feng, Min, et al.
Publicado: (2020)

Antiviral Peptides as Anti-Influenza Agents
por: Agamennone, Mariangela, et al.
Publicado: (2022)

Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases
por: Madanchi, H., et al.
Publicado: (2019)

Recently FDA-approved drug: A new hope for vitiligo patients?
por: Siddiq, Mohammad Arham, et al.
Publicado: (2022)

FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms
por: Ahmed, Mahmoud S., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer’s disease amyloid-β peptides
por: Lei, Xiling, et al.
Publicado: (2015)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022)

Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease
por: Martini, Dylan J, et al.
Publicado: (2022)

Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides
por: Mulder, Kelly C. L., et al.
Publicado: (2013)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
por: Ginex, Tiziana, et al.
Publicado: (2021)

The Potential of Antiviral Peptides as COVID-19 Therapeutics
por: Mahendran, Arun Suria Karnan, et al.
Publicado: (2020)

The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides
por: Pärn, Kalle, et al.
Publicado: (2015)

A Review: The Antiviral Activity of Cyclic Peptides
por: Chia, Le Yi, et al.
Publicado: (2022)

An Overview of Antiviral Peptides and Rational Biodesign Considerations
por: Lee, Ying-Chiang J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ickj7qpr2520k6cm2lmjq1nr7a